Vendor Intelligence Report: Oupeptide

Published 3 Jul 2026. 27-page investigative report on who is behind Oupeptide: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Across 179 Finnrick lab tests, Oupeptide records 128 pass / 51 fail for a 72% overall pass rate, with GHK-Cu strongest, tirzepatide and retatrutide more defensible, and tesamorelin the clearest…